Cite
Targeted and untargeted serum NMR metabolomics to reveal initial kidney disease in diabetes mellitus.
MLA
Lucio-Gutiérrez, J.Ricardo, et al. “Targeted and Untargeted Serum NMR Metabolomics to Reveal Initial Kidney Disease in Diabetes Mellitus.” Journal of Pharmaceutical & Biomedical Analysis, vol. 247, Sept. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.jpba.2024.116240.
APA
Lucio-Gutiérrez, J. R., Cordero-Pérez, P., Ávila-Velázquez, J. L., Torres-González, L., Farías-Navarro, I. C., Govea-Torres, G., Sánchez-Martínez, C., García-Hernández, P. A., Coello-Bonilla, J., Pérez-Trujillo, M., Parella, T., Waksman-Minsky, N. H., & Saucedo, A. L. (2024). Targeted and untargeted serum NMR metabolomics to reveal initial kidney disease in diabetes mellitus. Journal of Pharmaceutical & Biomedical Analysis, 247, N.PAG. https://doi.org/10.1016/j.jpba.2024.116240
Chicago
Lucio-Gutiérrez, J. Ricardo, Paula Cordero-Pérez, José Luis Ávila-Velázquez, Liliana Torres-González, Iris C. Farías-Navarro, Gustavo Govea-Torres, Concepción Sánchez-Martínez, et al. 2024. “Targeted and Untargeted Serum NMR Metabolomics to Reveal Initial Kidney Disease in Diabetes Mellitus.” Journal of Pharmaceutical & Biomedical Analysis 247 (September): N.PAG. doi:10.1016/j.jpba.2024.116240.